Skip to main content

Address And Details

225 South Lake Avenue , Pasadena, CA 91101
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The PRIMECAP Odyssey Aggressive Growth Fund seeks to provide long-term capital appreciation.The Fund invests primarily in the common stocks of U.S. companies, emphasizing those companies with prospects for rapid earnings growth. The Fund may invest in stocks across all market sectors and market capitalizations and has historically invested significant portions of its assets in mid-and small-capitalization companies. Because of the bottom-up stock selection process of PRIMECAP Management Company (the Advisor), the Fund may maintain a significantly overweight or underweight position in a particular sector relative to the S&P 500 index, a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market, at any time. The Fund may also invest substantial assets in foreign securities through depository receipts or stocks traded on U.S. or foreign exchanges.The Advisor, through its fundamental research, seeks to identify stocks that are poised for rapid earnings growth. Catalysts for the desired growth may include new products, new markets, new management, restructuring, a structural shift in demand or supply, or other changes in industry dynamics. These stocks typically provide little or no current income. The Advisor looks for companies that, in its judgment, will grow faster and/or will be more profitable than their current market valuations suggest and for companies with asset values that are not adequately reflected in their stock prices. The Advisor may sell a stock if its market price appears to have risen above its fundamental value, if other securities appear to be more favorably priced, if the reasons for which the stock was purchased no longer hold true, or for other reasons. The Advisor maintains a long-term focus and attempts to identify stocks that it believes will outperform the S&P 500 index over a three-to five-year time frame.

Net Asset Value

as of 5:03 PM ET 12/03/2021

Performance

  • 1 Week
  • -4.42%
  • 1 Month
  • -9.99%
  • 3 Months
  • -7.20%
  • 1 Yr Return
  • +1.56%
  • 5 Yr Return
  • +58.68%

Equity Sector Breakdown

Technology 28.25%
Health 26.87%
RetailTrade 10.25%
IndustrialCyclical 8.77%
Services 6.47%
Finance 6.05%
NonDurables 2.27%
ConsumerDurables 0.93%
Utilities 0.73%
Energy 0.47%

Asset Allocation

Asset Type % Of Allocation
Stocks 97.20%
ForeignStocks 8.58%
Preferred 0.02%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 11.74 B

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -2.78 -0.61 0.96
Beta 1.04 1.09 1.12
R Squared 0.77 0.70 0.68
Std Deviation 21.83 19.94 17.71
Sharpe Ratio 0.91 1.01 n/a

Purchase Information

as of 5:26 PM ET 12/02/2021
Minimum Initial n/a
Minimum Additional $100
Minimum Initial IRA $99

Performance

Timeframe Average Annual Current Performance Monthly As Of 11/30/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 11/30/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • +14.75%
  • +30.20%
+14.75% +30.20%
3 Year
  • +15.75%
  • +10.69%
+15.75% +10.69%
10 Year
  • +18.52%
  • +19.55%
+18.52% +19.55%
Life Of Fund
  • +14.12%
  • +14.16%
+14.12% +14.16%

Top 10 Holdings

Symbol Company Name % Of Assets
BNTX BIONTECH SE 4.74%
SONY SONY CORP SPONSORED ADR 3.21%
MU MICRON TECHNOLOGY INC 3.19%
BGEN BIOGEN INC 2.74%
ABMD ABIOMED INC 2.56%
TSLA TESLA INC 2.55%
LLY ELI LILLY & CO 2.46%
SGEN SEAGEN INC 2.29%
BGNE BEIGENE LTD 2.12%
SPLK ~SPLUNK INC 2.00%

LATEST NEWS

Recent Articles from TheStreet

Expensive Healthcare Lead

Pear Therapeutics Stock to Begin Trading After SPAC Merger

Pear Therapeutics received its second breakthrough device designation from the Food and Drug Administration for its reSET-A product candidate that is designed for the treatment of alcohol substance use disorder.

SpaceX Lead

Elon Musk's SpaceX Building Starship Launch Pad for Mars, Moon Trips

SpaceX CEO Elon Musk tweets Saturday that the company has started construction on an orbital launch pad at the Kennedy Space Center in Florida for missions to the Moon and Mars.

IM Cannabis Lead

What's Next for Planet 13: A U.S. Listing, Chicago, and Florida

The company solidifies its hold on Nevada while launching its California Superstore and planning a U.S. stock listing as well as moves into Chicago and Florida.

iRobot Roomba 870 Vacuum Cleaning Robot

Robot Vacuums, Air Fryers, Hermes Bags: What Shoppers Bought Cyber Monday

Based on Cyber Mondays sales, robot vacuums are on a lot of holiday gift lists this year, with sales of the home appliances up 2,250% from last year.

Tech Rally Sends Hang Seng To Best Gain This Month As Traders Weigh Covid-19 Fallout In China

Market Dancing Like a 'Puppet on a String'

In the current state of the world, investors are ignoring two key truths, Jim Collins says.

Wall Street Lead

Cramer's Mad Money Recap 12/3: DocuSign, GameStop, Costco

Valuations for many stocks are high, says Jim Cramer. That means investors should be on the lookout for potential shocks and new buying opportunities.

lazy bear sh

The Bear is Hiding in Plain Sight

James 'Rev Shark" Deporre says the disconnect between mega cap stocks holding up the market indexes and struggling shares of many other companies is only getting worse.

Elaine Paul Lead

Lyft Taps Amazon, Disney Veteran Elaine Paul as CFO

Paul has worked at Amazon Studios and Disney in the past and led teams across finance, strategy, analytics and technology.

Facebook Lead

Facebook Tests Bill-Splitting Feature In Messenger

Known as Split Payments, the feature is set to launch for U.S. users next week.

Facebook Meta Logo Lead

Facebook in Bear Market, but Morningstar Says It's Undervalued

'We have continue to rate [Meta Platforms] a wide-moat firm with a solid network effect and intangible assets,' Morningstar said.